Systematic literature review of the epidemiology of glycogen storage disease type 1a

J Pediatr Endocrinol Metab. 2023 Aug 25;36(9):809-817. doi: 10.1515/jpem-2023-0127. Print 2023 Sep 26.


Glycogen storage disease (GSD) type 1a is an inherited autosomal recessive metabolic disease caused by a deficiency in glucose-6-phosphatase activity. The objectives of this research were to systematically review the published literature on the epidemiology of GSD 1a and to assess the performance of reported epidemiology measures in a simulation model. In this systematic literature review 2,539 record titles and abstracts were screened. Of these, only 11 studies contained relevant data on GSD 1a disease epidemiology. Reported disease frequency ranged from 0.085/100,000 to 10.3/100,000 newborns when considering all the GSD literature. When this was narrowed to GSD 1 and GSD 1a, the range was tightened to 0.25-3.02/100,000 and 0.085-4.9/100,000 newborns, respectively. Most of the identified studies counted the number of diagnoses in a defined period and related to the number of births in the same (Dx method) or different time period (DoB method). The simulation model results indicate that in most of the situations, the Dx method provides a closer estimate to the true disease incidence than the DoB method. Despite the scarcity of epidemiology data, the results of this systematic review strongly support that GSD 1a and its parent disease groups (GSD and GSD 1) are rare diseases.

Keywords: GSD 1a; epidemiology; glycogen storage disease type 1a; prevalence; simulation modelling; systematic literature review.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Female
  • Glucose-6-Phosphatase
  • Glycogen Storage Disease Type I* / epidemiology
  • Humans
  • Infant, Newborn
  • Parents
  • Parturition
  • Pregnancy


  • Glucose-6-Phosphatase

Supplementary concepts

  • Hepatorenal form of glycogen storage disease